Skip to main content

Advertisement

Log in

Molecular Pathogenesis of Liver Cancer

  • Review Article
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. El-Serag HB. Hepatocellular carcinoma. N Engl J med. 2011;365:1118–27.

    Article  CAS  Google Scholar 

  2. Alotaibi H, Atabey N, Diril K, Erdal E, Ozturk M. Molecular Mechanisms of hepatocellular carcinoma. In: Current clinical oncology 2016—hepatocellular carcinoma diagnosis and treatment, pp 43–63, BI Carr (editor), Springer, 2016.

  3. Ozen C, Yildiz G, Dagcan AT, Cevik F, Ors A, Keles U, et al. Genetics and epigenetics of liver cancer. New Biotechnol. 2013;30:381–4.

    Article  CAS  Google Scholar 

  4. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

    Google Scholar 

  5. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379:1245–55.

    Article  Google Scholar 

  6. El-Serag HB, Kanwal F. Obesity and hepatocellular carcinoma: hype and reality. Hepatology. 2014;60:779–81.

    Article  Google Scholar 

  7. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97–101.

    Article  CAS  Google Scholar 

  8. Buendia MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol. 2002;39:530–5.

    Article  Google Scholar 

  9. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet. 2012;44:694–8.

    Article  CAS  Google Scholar 

  10. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature. 1980;286:533–5.

    Article  CAS  Google Scholar 

  11. Brechot C, Gozuacik D, Murakami Y, Paterlini-Brechot P. Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Semin Cancer Biol. 2000;10:211–31.

    Article  CAS  Google Scholar 

  12. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet. 2012;44:760–4.

    Article  CAS  Google Scholar 

  13. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S a. 1990;87:1973–7.

    Article  CAS  Google Scholar 

  14. Ozturk M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver dis. 1999;19:235–42.

    Article  CAS  Google Scholar 

  15. Ozturk M, Arslan-Ergul A, Bagislar S, Senturk S, Yuzugullu H. Senescence and immortality in hepatocellular carcinoma. Cancer Lett. 2009;286:103–13.

    Article  CAS  Google Scholar 

  16. Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44:1117–21.

    Article  CAS  Google Scholar 

  17. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al. TERT promoter mutations in familial and sporadic melanoma. Science. 2013;339:959–61.

    Article  CAS  Google Scholar 

  18. Killela PJ, Reitman ZJ, Jiao Y, Bettegowda C, Agrawal N, Diaz LA, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S a. 2013;110:6021–6.

    Article  CAS  Google Scholar 

  19. Liu X, Wu G, Shan Y, Hartmann C, von Deimling A, Xing M. Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma. Cell Cycle. 2013;12:1637–8.

    Article  CAS  Google Scholar 

  20. Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, et al. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology. 2014;60:1983–92.

    Article  CAS  Google Scholar 

  21. Nonoguchi N, Ohta T, Oh J-E, Kim Y-H, Kleihues P, Ohgaki H. TERT promoter mutations in primary and secondary glioblastomas. Acta Neuropathol. 2013;126:931–7.

    Article  CAS  Google Scholar 

  22. Cevik D, Yildiz G, Ozturk M. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinoma from different geographical locations. World J Gastroenterol. 2015;21:311–5.

    Article  CAS  Google Scholar 

  23. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat med. 2011;17:330–9.

    Article  CAS  Google Scholar 

  24. Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet dev. 2012;22:50–5.

    Article  CAS  Google Scholar 

  25. Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2012;342:223–30.

    Article  Google Scholar 

  26. Sceusi EL, Loose DS, Wray CJ. Clinical implications of DNA methylation in hepatocellular carcinoma. HPB (Oxford). 2011;13:369–76.

    Article  Google Scholar 

  27. Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol. 2010;6:402.

    Article  Google Scholar 

  28. Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y, et al. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer res. 2012;18:4997–5007.

    Article  CAS  Google Scholar 

  29. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25:2537–45.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author’s research is supported by grants from the TÜBİTAK (109S191 and 111T558) with additional support from the Ministry of Development and Turkish Academy of Sciences.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehmet Ozturk.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozturk, M., Batur, T., Ekin, U. et al. Molecular Pathogenesis of Liver Cancer. J Gastrointest Canc 48, 222–224 (2017). https://doi.org/10.1007/s12029-017-9957-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-017-9957-2

Keywords

Navigation